12 Best Nasdaq Stocks Under $20 to Buy Now
The Nasdaq has had a challenging start to 2025, with the index dropping nearly 12% YTD, as of March 13.
Amicus Therapeutics Inc. (FOLD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 24,245,952 | $228,396,868 | -14% | 6.29% |
| 2. | VenBio Select Advisor Kurt Von Emster | 23,175,000 | $218,308,500 | 3.08% | |
| 3. | Citadel Investment Group Ken Griffin | 8,239,949 | $77,620,320 | +127% | 0.01% |
| 4. | Palo Alto Investors William Leland Edwards | 7,662,479 | $72,180,552 | -6% | 11.18% |
| 5. | Redmile Group Jeremy Green | 7,054,890 | $66,457,064 | -15% | 4.63% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.49 | 1,500 | Director | 65,082 | 2021-11-01 | Filing | |
| $9.56 | 1,500 | Director | 63,582 | 2021-10-01 | Filing | |
| $11.41 | 1,500 | Director | 62,082 | 2021-09-01 | Filing | |
| $9.28 | 1,500 | Director | 60,582 | 2021-08-02 | Filing | |
| $9.24 | 1,500 | Director | 47,467 | 2021-06-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.00 | 400 | 1,150,657 | 2025-02-19 | Filing | ||
| $10.02 | 7,500 | 886,654 | 2024-12-02 | Filing | ||
| $12.50 | 7,901 | 886,654 | 2024-11-06 | Filing | ||
| $11.46 | 7,500 | 886,654 | 2024-11-01 | Filing | ||
| $10.60 | 7,500 | 886,654 | 2024-10-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 633 | $5,165 | 0% | |
| 2. | 409 | $3,337 | 0% |
News See All
12 Stocks Under $10 With High Upside Potential
Small-cap stocks in the U.S. have suffered as the broader market is under pressure due to the ongoing tariff policy transition.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of obesity...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Amicus Therapeutics Full Year 2024 Financial Results Conference Call and Webcast.
Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Amicus Therapeutics Third Quarter 2024 Financial Results Conference Call and Webcast.
10 Best Guru Stocks To Buy Now
Due to the plethora of investment options such as equities, bonds, and mutual funds that are available today, picking the right set of vehicles to either preserve or grow money can often seem to be a ...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q2 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Amicus Therapeutics Second Quarter 2024 Financial Results Conference Call and Webcast.